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Abstract 
Background: An accurate estimate of Plasmodium vivax prevalence is essential for the successful implementation 
of malaria control and elimination programmes. Prevalence estimates both inform control strategies and are used in 
their evaluation. Light microscopy is the main method for detecting Plasmodium parasitaemia in the peripheral blood, 
but compared to molecular diagnostics, such as polymerase chain reaction (PCR), has limited sensitivity.
Methods: A systematic review and meta‑analysis was conducted to assess the effect of detection method on the 
prevalence of P. vivax and to quantify the extent to which P. vivax infections are undetected by microscopy. Embase, 
Medline and the Cochrane Database were searched for studies reporting prevalence by PCR and by microscopy and 
that contained all of the following key words: vivax, PCR, and malaria. Prevalence estimates and study meta‑data were 
extracted systematically from each publication. Combined microscopy:PCR prevalence ratios were estimated by ran‑
dom effects meta‑analysis. Sensitivity and specificity of microscopy were calculated using PCR as the gold standard.
Results: Of 874 studies reviewed, 40 met the criteria for inclusion contributing 54 prevalence pairs. The prevalence 
of P. vivax infection measured by PCR was consistently higher than the prevalence measured by microscopy with 
sub‑patent parasitaemia. The mean prevalence of infection detected by microscopy was 67 % (95 % CI 59–73 %) 
lower than the prevalence detected by PCR. The detection of sub‑patent parasitaemia did not vary according to the 
microscopy method (thick or, thick and thin smears), the PCR prevalence (as a measure of the true P. vivax prevalence), 
the type of blood used or DNA extraction method.
Conclusions: Quantifying P. vivax parasitaemia by PCR rather than microscopy consistently increased prevalence esti‑
mates by a factor of 2.3. Whilst the sensitivity of microscopy can be improved by better methods, molecular methods 
have potential to be scaled up to improve the detection of P. vivax transmission reservoirs.
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Background
Almost half of the world’s population is at risk of infec-
tion with Plasmodium vivax [1]. Most cases originate in 
South East Asia and the Western Pacific and a significant 
number occur in South America and the Horn of Africa 
[1, 2]. P. vivax is associated with substantial morbidity 
and severe and fatal disease in endemic countries [3–6]. 
P vivax infection is characterized by comparatively low 
parasitaemia compared to Plasmodium falciparum, and 
in co-endemic regions vivax parasitaemia is often con-
servatively documented as P. falciparum reducing the 
reported prevalence [3]. Many nations evaluating their 
prospects for malaria elimination are endemic for P. vivax 
and as successful control programmes reduce the risk of 
P. falciparum the relative proportion of P. vivax infection 
rises. Accurate data on P. vivax prevalence and transmis-
sion patterns is important for the progress of elimination 
campaigns and focusing malaria control efforts [4].
Light microscopy examination of blood films is 
the main method for detecting peripheral parasitae-
mia and for differentiation of Plasmodium species 
[5]. The World Health Organization (WHO) guide-
lines for malaria diagnosis and treatment recommend 
that malaria treatment be given only after a positive 
parasitological test result from either microscopy or a 
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rapid diagnostic test (RDT) [6]. The advantages of light 
microscopy make it an ideal diagnosis tool in resource 
poor settings however its accuracy depends upon the 
technician’s skill level and can be adversely affected by 
operational constraints or technical problems. Low-
density infections often remain undetected by micros-
copy [7, 8]. As P. vivax is characterized by low level 
parasitaemia microscopy may not be the most appro-
priate tool for accurate diagnosis. Molecular methods, 
e.g. polymerase chain reaction (PCR), depend on DNA 
amplification approaches and have higher sensitivity 
than microscopy [9]. Despite the greater sensitivity of 
PCR it is not widely used due to the lack of a stand-
ardized methodology, high costs, and the need for 
highly-trained staff. PCR is increasingly used in epide-
miological studies, but rarely used in routine clinical 
diagnosis.
Most P. vivax cases occur in low transmission settings 
where asymptomatic carriage occurs relatively frequently 
[10]. With the reliance on symptoms driving the presen-
tation of infected patients and microscopy used as the 
main diagnosis tool, asymptomatic and sub-microscopic 
infections are likely to remain undetected and untreated 
in vivax endemic populations. Sub-microscopic infec-
tions of P. falciparum have been shown to infect mosqui-
toes and transmit malaria [11]. Sub-microscopic P. vivax 
infections may similarly contribute to the infectious res-
ervoir and maintain transmission. A review on asymp-
tomatic malaria in Brazil highlighted the importance of 
accurate diagnosis and detection of all Plasmodium cases 
for the malaria control programmes to be effective [7]. A 
prevalence ratio reported from a study in Peru indicates 
that 78  % of infections would go undetected if micros-
copy alone was used in surveillance programmes [8]. In 
a study from Iran microscopy did not detect any vivax 
infection in the 900 samples, whereas PCR detected ten 
positive samples out of 871 [12].
In a review exploring the proportion of sub-micro-
scopic P. falciparum infections, Okell et al. documented 
reduced sensitivity of microscopy which detected on 
average 50  % of falciparum infections detected by PCR 
[13]. Cheng et  al. recently reviewed 25 publications (31 
surveys) from 1996 to 2010 reporting a mean of 69.5 % 
sub-microscopic P. vivax infections [14]. The current 
review extends the work of Cheng et al. with a meta-anal-
ysis and the inclusion of additional studies; since 2010, a 
further 11 prevalence studies reported microscopy and 
PCR P. vivax prevalence and an additional seven were 
identified from 1996 to 2010. The aim was to re-quan-
tify the extent of sub-microscopic P. vivax infections 
detected by PCR and identify whether this ratio varies 
with transmission intensity, location of study or labora-
tory methods.
Methods
This systematic review used a predefined protocol and 
followed the PRISMA guidelines [15]. PubMed, EMBASE 
and the Cochrane Library were searched using MeSH 
search terms and Boolean operators: “malaria” AND 
“PCR” AND “vivax” up to the 15 September 2014. The 
search was restricted to English language publications 
with no time limits. Results of each search were exported 
and duplicates removed. This high-yield search strat-
egy was used to ensure capture of all relevant articles. 
Titles and abstracts of all articles were initially scanned 
to identify prevalence studies. Case reports, case series, 
efficacy studies, entomological surveys, non-human stud-
ies, immunological studies, genetic sequencing studies 
and other non-relevant articles were excluded. Full texts 
of articles identified as potentially relevant in this initial 
screen were assessed against the full eligibility criteria 
using a standardized form. References of relevant articles 
were scanned to identify additional studies.
Selection criteria
Eligible studies reported the prevalence of P. vivax by 
microscopy and PCR in the same population living in 
a malaria endemic country. If only a subset of partici-
pants were tested by microscopy or PCR, the study was 
included providing the subset was selected randomly. 
Exclusion criteria included: studies of imported malaria, 
studies where a large-scale intervention was imple-
mented before the measurement of prevalence (e.g. 
insecticide-treated bed nets or mass drug administra-
tion), studies in pregnant women, studies that select par-
ticipants based on parasitaemia levels, malaria symptoms 
or malaria diagnosis, studies of a population not repre-
sentative of a defined endemic area (e.g. studies in refu-
gees or migrant workers), studies with less than 20 blood 
samples tested by either method, and studies where no 
P. vivax was detected by PCR or microscopy. When the 
presence of malaria symptoms was not specifically stated 
it was assumed that participants seeking treatment or 
care at health facilities were symptomatic and these stud-
ies were excluded. In cohort studies, data were extracted 
from the baseline observation only.
Data extraction
From each eligible study the following information was 
extracted: month and year of sample collection, loca-
tion, age criteria for inclusion, age range of included par-
ticipants, prevalence of P. vivax malaria by microscopy, 
prevalence of P. vivax malaria by PCR, number of false-
positives (i.e. number of samples microscopically posi-
tive and PCR negative) and number of false-negatives 
(i.e. number of samples microscopically negative and 
PCR positive) and PCR and microscopy methodology. 
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Authors were not contacted for further information and 
no studies were excluded on the basis of quality.
Statistical analysis
The parasite prevalence by microscopy and PCR were cal-
culated for each study, once for P. vivax monoinfections 
and again for all P. vivax infections (i.e. infections where 
P. vivax was detected either alone or with any other Plas-
modium species). Prevalence of infection detected by 
microscopy was compared to the prevalence of infec-
tion detected by PCR to produce a microscopy:PCR 
prevalence ratio and the sub-microscopic prevalence 
was calculated as: PCR prevalence minus the microscopy 
prevalence. PCR was considered the reference standard 
and the numbers of false-positives and false-negatives 
were used to calculate sensitivity and specificity estimates 
for microscopy when this information was available. Log 
transformed microscopy: PCR prevalence ratios and the 
sample size for each study were used to derive inverse-
variance weighted fixed effects and random effects meta-
analysis combined estimates [16]. The Kruskal–Wallis 
method was used for nonparametric comparisons, and 
Student’s t test for parametric comparisons. For categori-
cal variables percentages and corresponding 95 % confi-
dence intervals (95 % CI) were calculated using Wilson’s 
method. Proportions were examined using χ2 with Yates 
correction or by Fisher’s exact test. The Chi squared het-
erogeneity statistic was used to assess the between-study 
heterogeneity. Forest plots and combined random-effects 
estimates were produced for sub groups (e.g. microscopy 
method) to determine if heterogeneity was accounted for 
by any methodological differences. All analyses were per-
formed using Stata software (11.0; StataCorp).
Results
Literature search
A search of Pubmed, EMBASE and the Cochrane Library 
identified 874 unique publications; 182 were selected for 
full text evaluation. Forty met all eligibility criteria (Fig. 1) 
[8, 12, 17–54]. Details for the exclusion of full text articles 
are provided in Additional file 1. The most common rea-
sons for exclusion were surveys of patients with malaria 
or malaria symptoms (N = 84), study was not population 
based (N = 24), prevalence from either method was not 
reported (N = 17) and samples chosen for PCR were not 
randomly selected (N  =  8). Five studies were excluded 
since no P. vivax parasites were detected either by PCR or 
by microscopy [55–59].
Description of included studies
Most of the 40 included studies were derived from cross–
sectional surveys (N = 31, 78 %), three were cohort stud-
ies [23, 47, 60] and three studies recruited participants 
via active case detection [30, 44, 46]. Three studies did 
not report the study design [23, 51, 61].
The sampling strategy was reported for 27 stud-
ies (68  %). In 14 (52  %) of these studies, all households 
were visited and informed consent sought from all eli-
gible residents. Five studies reported random sampling 
of individuals, two studies reported random sampling at 
the household level, one reported random sampling of 
schools where all students at the selected schools were 
included and one study reported multistage cluster sam-
ple with random cluster sampling of villages then random 
household sampling. Two studies reported convenience 
sampling (one of which provided no further information 
[36]) and the other took blood samples from all neigh-
bours of confirmed malaria cases admitted to hospital 
[20]. Two studies reported active case detection, one at 
mobile malaria clinics [26] and the other through contact 
tracing of confirmed malaria cases and high risk group 
screening [42].
The 40 publications yielded 54 pairs of microscopy 
and PCR prevalence estimates. In 14 studies prevalence 
was reported for different localities which were analysed 
as independent observations. Two studies compared 
microscopy to two different PCR methods contribut-
ing two paired prevalence estimates [47, 62]. Key study 
features are highlighted in Additional file 2. Most preva-
lence estimates were from Papua New Guinea (N = 13) 
and Brazil (N = 13). Only two prevalence pairs were from 
Africa and one from the Middle East. Blood samples 
were collected between 1996 and 2012, with the majority 
collected after 2004 (N = 34). Eight studies did not report 
the year of sample collection. Most blood samples were 
from participants of all ages, five studies were restricted 
to children only (maximum age 3 or 5 years or age lim-
ited not reported), two restricted to adults aged more 
than 15 years and four studies did not report the age of 
participants (see Additional file 2).
In 73  % (29/40) of studies all blood samples were 
assessed by both microscopy and PCR. In five studies 
more than 90 % of microscopy samples were assessed by 
PCR [17, 21, 23, 28, 37]. For three prevalence estimates, 
8, 19 and 34  % of microscopy samples were randomly 
selected for molecular testing [36, 37]. One study tested 
85 % of microscopy samples by PCR but did not report 
how these samples were chosen [20], another tested 80 % 
of samples by PCR due to a reported difficulty in collect-
ing whole blood samples from children less than 5 years 
[8]. Another study selected all samples from villages 
where there was any microscopy-positive sample, plus a 
10  % random selection of microscopy-negative samples 
from all villages for testing by PCR [18]. In this last case, 
the majority of samples tested by PCR were not samples 
that were confirmed microscopy-positive (only 8 samples 
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Fig. 1 PRISM flow diagram. Study selection (PRISM flow diagram)
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out of 3223 tested by PCR were chosen because they 
were positive by microscopy), so this study was included. 
The final study selected 7 % of microscopy samples that 
were chosen to be representative of the age, gender and 
village composition for testing by PCR [61].
The overall median sample size was 504 (range 
79–16,229) for microscopy and 482 (range 79–8590) for 
PCR. Most microscopy measurements used thick and 
thin smears with Giemsa staining (N = 28), the remain-
ing studies (N = 12) used only thick smears with Giemsa 
staining. The most referenced PCR method was nested 
PCR using the protocol of Snounou et  al. (N =  18) [9]. 
Other reported PCR methods include the semi-quanti-
tative PCR (LDR-FMA) of McNamara, the semi-nested 
multiplex PCR of Rubio, various real-time PCR methods 
[22, 45, 62, 63] and one article reported using a newly 
designed mitochondrial-DNA-based PCR method [28].
All studies described the type of blood and DNA 
extraction method used for PCR analysis. Twenty studies 
(50 %) used whole blood (primarily >200 µL, N = 15), 17 
(42.5  %) used blood from filter paper, and three studies 
(7.5 %) reported using both blood from filter paper and 
whole blood for DNA extraction. Two of the three stud-
ies that reported both methods used filter paper for some 
surveys and whole blood for others and the other study 
used whole blood for participants aged >5 years and filter 
paper for participants <5 years.
Quality assessment
Only four studies reported blinding of technicians to 
results of the other detection method (i.e. microscopists 
blinded to PCR results and vice versa). Double reading of 
microscopy slides was reported for 40 prevalence pairs 
(74 %). Many studies reported the use of ‘expert’ micros-
copists and specified their training, years of experience 
or results when given a blinded test before the study 
started. Only seven studies reported blinding of the sec-
ond microscopists to the results of the first, most did not 
report if this occurred (N = 30). Nineteen studies (48 %) 
reported the use of negative controls during PCR.
Prevalence measurements
The prevalence of P. vivax infection measured by PCR 
was consistently higher than the prevalence measured 
by microscopy (Fig.  2). One study reported a preva-
lence by microscopy higher than the prevalence by PCR 
[39]. The mean prevalence by PCR was 18  % (95  % CI 
13.3–23.4) and the mean prevalence by microscopy was 
7.8 % (95 % CI 4.4–11.1). Forty-two of the 54 prevalence 
pairs reported the prevalence of P. vivax monoinfections 
(infection with P. vivax only) separately from the preva-
lence of all P. vivax infections (mono or mixed infections). 
The variation in prevalence was greater when including 
mixed infections compared to including monoinfections 
only, i.e. concordance between the two techniques was 
greater when considering monoinfections only (Fig.  2). 
PCR detected mixed infections in 1.8 % of parasitaemias 
compared to 0.65  % detected by microscopy. For nine 
prevalence pairs, P. vivax parasitaemia was not detected 
by microscopy but was detected by PCR (PCR prevalence 
range 0.18–11.2 %). The prevalence of sub-microscopic P. 
vivax ranged from 0.01 to 48.8 % and was higher in the 
Asia Pacific region [mean =  18  % (range 0.32–48.8  %)] 
compared to South America [9.4 % (range 0.34–31.3 %); 
p = 0.02] and Asia [1.7 % (range 0.01–29.8 %); p = 0.001]. 
There was no statistical difference in the prevalence of 
sub-microscopic P. vivax between Asia and South Amer-
ica (p = 0.18; Fig. 3).
Prevalence ratios
Prevalence ratios were calculated for 83 % (45/54) of the 
prevalence pairs; in the remaining nine pairs no P. vivax 
was detected by microscopy precluding derivation of a 
ratio. A forest plot of the prevalence ratios with 95 % con-
fidence intervals is shown in Fig. 4. The prevalence ratios 
were highly heterogeneous between studies and ranged 
from 0.03 to 1.49 (heterogeneity Chi squared =  936.51, 
p < 0.001, Fig. 4). The combined microscopy: PCR preva-
lence ratio estimate using random effects at the study 
level was 0.33 (95 % CI 0.27–0.41), i.e. the prevalence of 
infection detected by microscopy was 67  % lower than 
the prevalence of infection detected by PCR. The corre-
sponding figure when considering monoinfections only, 
Fig. 2 PCR P. vivax prevalence versus microscopy P. vivax prevalence, 
monoinfections and mixed infections. Scatter plot of the prevalence 
of P. vivax infection as determined by PCR versus prevalence of P. vivax 
as detected by microscopy. Prevalence pairs including only mono‑
infections (infections with only P. vivax) are shown in open circles and 
the prevalence pairs including all infections (P. vivax monoinfections 
and P. vivax infections where another species is also detected) are 
shown in filled circles. The line shows the expected association if both 
techniques were equally sensitive
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was 0.37 (95  % CI 0.29–0.48). Overall the prevalence 
of infection detected by microscopy was 60  % (95  % CI 
36–75 %) lower than the prevalence of infection detected 
by PCR in Asia, 67 % (95 % CI 57–75 %) lower in the Asia 
Pacific and 72 % (95 % CI 58–81 %) lower in South Amer-
ica. Studies from South America were less heterogeneous 
(heterogeneity Chi squared  =  88.03) compared to Asia 
(185.07) and Asia Pacific (88.03).
The combined prevalence ratio estimates did not vary 
between studies that used thick and thin smears for 
microscopy and those that used thick smears only. Like-
wise the prevalence ratio did not vary between studies 
that used filter paper for DNA extraction compared to 
those that used whole blood. However the majority of 
prevalence pairs (14/23) that used whole blood were from 
Asia, whereas prevalence pairs that reported filter paper 
for DNA extraction were from the Asia Pacific region 
(14/28) or South America (10/28). Reporting the use of 
a negative control was not associated with a significant 
difference in the combined microscopy: PCR prevalence 
ratio: 0.36 (95 % CI 0.27–0.47) versus 0.31 (95 % CI 0.23–
0.42), (p =  0.24). Prevalence ratios did not significantly 
vary between studies that used nested PCR compared to 
other PCR techniques (p = 0.71). The microscopy: PCR 
prevalence ratio showed a weak positive association with 
the underlying PCR prevalence, increasing by 0.047 (95 % 
CI 0.002–0.09) per 10  % increase in PCR prevalence 
(Fig. 5).
Sensitivity and specificity
The sensitivity and specificity of microscopy was calcu-
lated for 20 prevalence paired estimates. Sensitivity and 
specificity were 0 and 100 % respectively for 7 prevalence 
pairs where no P. vivax parasites were detected by 
microscopy. Assuming that one sample was positive by 
both microscopy and PCR, and that one sample was posi-
tive by microscopy and negative by PCR allowed calcula-
tion of sensitivity and specificity for these seven studies; 
results are available in Additional file 3. Overall, micros-
copy was highly specific with less than 2 % false positives. 
However the sensitivity varied from 4.2 to 94 %.
Discussion
Data from 40 published studies show that PCR detects 
67 % more P. vivax infections than microscopy in surveys 
of endemic populations. This result is similar to findings 
by Cheng et  al. who reported on 25 studies in which P. 
vivax was not detected by microscopy in 69.5 % of esti-
mates. The additional 18 studies included in the current 
analysis generally reported higher prevalence by both 
microscopy and PCR; the mean PCR prevalence was 
18.6 % (range 0.18–73.2 %) compared to a range of PCR 
prevalence estimates of 0.2–59.5 % reported by Cheng.
Both reviews are also consistent with a literature 
review of P. falciparum PCR and microscopy prevalence 
reported by Okell and colleagues in which microscopy 
detected 51 % of all parasitaemias detected by PCR [13]. 
There are several characteristics of P. vivax infections 
that make diagnosis by microscopy more difficult than 
diagnosis of P. falciparum including the fact that P. vivax 
and P. falciparum are co-endemic in most vivax endemic 
areas and the detection of lower levels of P. vivax para-
sitaemia is difficult in the presence of higher levels of P. 
falciparum parasitaemia [3]. PCR has greater sensitivity 
to identify mixed infections [64], and this was apparent 
in the discrepancy between microscopy and PCR being 
greatest when considering all P. vivax infections (mono 
and mixed infections). Similar results are apparent in 
cross sectional surveys where PCR is as much as 30-fold 
more efficient at detecting mixed infections than micros-
copy alone [17]. The difference between prevalence ratios 
when detecting monoinfection and prevalence ratios 
when detecting all P. vivax infections, showed a similar 
trend although this did not reach statistically significance 
likely due to the limited number of prevalence pairs.
Only ten studies reported sensitivity and specificity 
measurements and these studies specifically aimed to 
measure these parameters for either PCR or microscopy. 
The wide range of microscopy sensitivities mirrored 
published sensitivities although microscopy sensitivity 
<50  % is less frequently reported in the literature than 
observed here. The sensitivity and specificity of micros-
copy is highly dependent on slide quality and the skill 
of microscopists [65]. Unfortunately these factors could 
not be considered in this analysis; both are subjective 
and rarely reported. The low prevalence of vivax malaria 
Fig. 3 Sub‑microscopic P. vivax prevalence by region. Box plots show‑
ing the median and the IQR of sub‑microscopic P. vivax prevalence by 
region (Asia Thailand, Sri Lanka, Lao PDR, Vietnam, Malaysia and Cam‑
bodia; Asia Pacific Indonesia and Papua New Guinea; South America 
Brazil, Venezuela and Peru)
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could explain the variability in sensitivity estimates as the 
number of positive results for both PCR and microscopy 
used in sensitivity calculations was small.
The studies included in this review are representative 
of the geographical distribution of P. vivax, with most 
but not all P. vivax endemic countries represented. The 
inclusion of only English publications introduced a bias 
towards studies from English speaking countries and a 
large number of potentially eligible publications from 
Brazil were not available in English [66]. The analysis 
focused on blood samples representative of endemic 
populations with a high proportion of included stud-
ies adopting comprehensive sampling strategies in an 
attempt to determine covariates in endemic populations; 
however the detection of sub-microscopic infections in 
high-risk groups or other populations excluded from this 
review also have public health relevance that warrants 
investigation.
Fig. 4 Ratios of the prevalence of P. vivax determined by microscopy to that determined by PCR. Forest plot displaying ratios (represented as closed 
diamonds) and 95 % confidence intervals (horizontal lines) of the prevalence of P. vivax detected by microscopy compared to that detected by PCR 
in 36 pair observations. The open diamond and broken vertical line represents the combined estimate from a random effects (D + L overall) meta‑
analysis, the combined estimate from a fixed effect (I − V overall) is also shown. The unbroken vertical line is at null value (1)
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With only 54 paired prevalence estimates included in 
this meta-analysis, the power to detect key covariates was 
limited. Studies where patients were selected on the basis 
of malaria symptoms were excluded and this one crite-
rion significantly reduced the number of studies available. 
Five studies were excluded as no P. vivax was detected by 
either technique, in addition, prevalence ratio could not 
be calculated for nine prevalence pairs when no P. vivax 
was detected by microscopy, the least sensitive detec-
tion method. Therefore, the extent to which microscopy 
failed to detect infections of P. vivax in low transmission 
areas is likely underestimated. Sample size is an impor-
tant consideration in the design of studies where few 
infections are detected. The studies in this review that did 
not microscopically detect any P. vivax infections but did 
detect vivax infections with PCR were of varying samples 
sizes and two were large studies (N = 3316, N = 1527). 
This indicates that when only using microscopy, increas-
ing the sample size alone will not allow detection of all 
existing P. vivax infections.
The detection limit of both techniques is depend-
ent on the volume of blood examined. In theory, less 
blood is examined using standard microscopy tech-
niques (~5  µL) than when a PCR assay is used [60, 
67]. This meta-analysis did not consider the exact 
volume of blood examined since the amount of blood 
used for DNA extraction for PCR was reported in 
only 18/40 studies and the amount of blood taken 
from participants reported in only 5/40 studies. 
Furthermore, nearly all studies that did report the 
amount of blood used for DNA extraction reported 
using 200  µL. The type of blood sample and DNA 
extraction method used for PCR analysis was exam-
ined and while the PCR prevalence was higher in 
studies that used whole blood versus studies that 
used filter paper this likely reflected regional vari-
ation and since the majority of studies using whole 
blood were from Asia and the majority of stud-
ies using filter paper being from the Asia Pacific or 
South America.
Future studies should examine the prevalence ratios 
of all malaria species in the same population to see if the 
sensitivity and specificity of microscopy and PCR var-
ies according to the species examined. Although PCR is 
unlikely to be routinely used for screening in low-income 
countries, quantification of sub-microscopic infections 
under different transmission settings could be used to 
accurately estimate the true prevalence of P. vivax infec-
tions. Mathematical models could predict the extent of 
sub microscopic infections given a number of key param-
eters on the population characteristics and the trans-
mission setting. Bayesian approaches have already been 
used to estimate disease prevalence in the absence of a 
gold standard diagnostic test or when the gold standard 
has imperfect sensitivity and specificity [68]. The current 
review has identified gaps in the information required 
for mathematical models designed to accurately esti-
mate prevalence of P. vivax infection. Health planning 
and decision making by malaria control and elimina-
tion programmes in P. vivax endemic areas will require 
reliable estimates of parasite prevalence. The results of 
this review highlight the benefits of investing in PCR 
techniques to inform malaria control programmes. In 
areas focused on elimination it is vital that all reservoirs 
of P. vivax malaria are detected especially since rates of 
asymptomatic carriage can be substantial with a known 
ability to transmit [69].
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